Ono, R., Nakayama, K., Nakamura, K., Yamashita, H., Ishibashi, T., Ishikawa, M., . . . Kyo, S. (2019). Dedifferentiated Endometrial Carcinoma Could be A Target for Immune Checkpoint Inhibitors (Anti PD-1/PD-L1 Antibodies). MDPI AG.
Style de citation ChicagoOno, Ruriko, et al. Dedifferentiated Endometrial Carcinoma Could Be A Target for Immune Checkpoint Inhibitors (Anti PD-1/PD-L1 Antibodies). MDPI AG, 2019.
Style de citation MLAOno, Ruriko, et al. Dedifferentiated Endometrial Carcinoma Could Be A Target for Immune Checkpoint Inhibitors (Anti PD-1/PD-L1 Antibodies). MDPI AG, 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.